COMP <GO>
BMI vs TMO // 10Y YIELD & FRED MACRO BETA
Badger Meter Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: BMI 13
— TMO 2
▲ 10Y YIELD & FRED MACRO BETA LEADER: BMI
LAST: $148.38 (-0.87%) • MKT CAP: $4.28B
macro-sensitivity
1.14
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
macro-sensitivity
0.94
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BMI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BMI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.70% | 41.00% | +0.70 | BMI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.30% | 9.30% | +9.00 | BMI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.3x | 30.4x | -8.10 | BMI | /valuation <GO> |
| Free Cash Flow Yield | 3.97% | 2.40% | +1.57 | BMI | /fcf-yield <GO> |
| Operating Margin | 20.00% | 17.40% | +2.60 | BMI | /operating-margins <GO> |
| Net Profit Margin | 15.50% | 15.10% | +0.40 | BMI | /net-margins <GO> |
| Revenue Growth (YoY) | 10.90% | 3.90% | +7.00 | BMI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.02% | 0.24% | +0.78 | BMI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.42 | 4.50 | +3.92 | BMI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | BMI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.70% | +0.70 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.2 | 59.1 | +3.04 | BMI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.14 | 0.94 | +0.20 | BMI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.1x | 36.3x | -8.20 | BMI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.28B | $262.22B | -$257.94B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BMI REV | TMO REV | BMI GROSS % | TMO GROSS % | BMI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $916.7M | $44.56B | 41.7% | 44.0% | $169.7M | $6.29B |
| FY 2024 | $826.6M | $42.88B | 39.8% | 44.0% | $142.2M | $7.27B |
| FY 2023 | $703.6M | $42.86B | 44.0% | 44.0% | $78.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BMI // BETA 1.14
TMO // BETA 0.94